Covid-19 in schools – everything you need to know

schools

The challenges of Covid-19 are particularly difficult for schools, nurseries and childcare providers. Attempting to socially distance within a school environment, particularly for younger children is extremely difficult. Despite this, most Education and childcare settings remain open. This is mainly for priority groups during the Coronavirus lockdown measures (vulnerable children and children of critical workers). The Government […]

Read More… from Covid-19 in schools – everything you need to know

Covid-19 cervical screening – what to expect?

“What to expect when going for cervical screening” is part of the ‘How it works now‘ series from Jo’s Cervical Cancer Trust, aimed at helping women to navigate how the healthcare system works during the pandemic. One common question we are asked is what to expect when going for cervical screening at the moment. This […]

Read More… from Covid-19 cervical screening – what to expect?

Imperial to begin first human trials of new Covid-19 vaccine

human trials

Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London. The study will be the first time the vaccine has been trialled in humans and will test whether it is well-tolerated and produces an effective immune response against COVID-19. Imperial’s vaccine candidate is […]

Read More… from Imperial to begin first human trials of new Covid-19 vaccine

Funding for Aberdeen Covid-19 “warning sign” study

radon

A University of Aberdeen study that aims to identify crucial biological ‘warning signs’ of an aspect of Covid-19 is to be supported by almost £100,000 from NHS Grampian Endowments. Dr Nicola Mutch and her team will look for defining key ‘biomarkers’ of a specific aspect of Covid-19. Up to one third of patients hospitalised for […]

Read More… from Funding for Aberdeen Covid-19 “warning sign” study

Africa records over 200 000 Covid-19 deaths

africa

Brazzaville, 10 June 2020 – COVID-19 continues to spread in Africa since the virus was first detected on the continent in mid-February 2020. More than 200 000 cases have been confirmed so far, with more than 5600 deaths. The pandemic is accelerating – it took 98 days to reach 100 000 cases and only 18 […]

Read More… from Africa records over 200 000 Covid-19 deaths

Kawasaki-like syndrome linked to COVID-19 in children is a new condition

A study on children suffering from severe inflammatory symptoms shows the condition is new and distinct from Kawasaki disease. In April, researchers in the UK and several European countries with high numbers of COVID-19 cases recognised a new inflammatory syndrome in children that was similar to Kawasaki disease, a rare syndrome known to affect young […]

Read More… from Kawasaki-like syndrome linked to COVID-19 in children is a new condition

BGS statement on BAME health workers

BAME

As the COVID-19 pandemic has progressed, it has become clear that the Black, Asian and minority ethnic (BAME) community is bearing a disproportionate share of deaths from the virus. The diversity of society in the UK is something we should be proud of. Nowhere is this more reflected than in the workforce of the NHS; […]

Read More… from BGS statement on BAME health workers

Leading cancer expert calls for five point action plan to kick start cancer services

cancer

Professor Karol Sikora, chief medical officer at Rutherford Health and the former head of the WHO’s cancer programme, called for the action plan as the NHS and the government explore urgent measures to kick start cancer services across the UK. Professor Sikora’s five-point plan includes: Keeping cancer centres and treatment areas ‘Covid-free’ – this should […]

Read More… from Leading cancer expert calls for five point action plan to kick start cancer services

Imperial social enterprise to accelerate low-cost COVID-19 vaccine

vaccine

Imperial College London has formed a new social enterprise VacEquity Global Health (VGH) to bring its COVID-19 vaccine to the world. For the UK and low-income countries abroad, Imperial and VGH will waive royalties and charge only modest cost-plus prices to sustain the enterprise’s work, accelerate global distribution and support new research. The social enterprise’s […]

Read More… from Imperial social enterprise to accelerate low-cost COVID-19 vaccine

Vaccines Manufacturing and Innovation Centre Signs First Industry Partnership

vaccines

The Vaccines Manufacturing and Innovation Centre (VMIC), a not-for-profit organisation established to provide the UK’s first strategic vaccine development and advanced manufacturing capability has signed its first industry partnership agreement with gene and cell therapy group Oxford Biomedica plc. The agreement signed today involves the organisations collaborating to enable scaled-up manufacture of viral vector based […]

Read More… from Vaccines Manufacturing and Innovation Centre Signs First Industry Partnership